TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16278188

Group type: EXPERIMENTAL
Intervention: Skin traction
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Lasse pillow
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Ordinary pillow
Number of subjects: 123
Study: 12200762

Group type: EXPERIMENTAL
Intervention: Fiber and vitamin combination therapy
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 10416312

Group type: COMPARATOR
Intervention: Normolipemics (Group A)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Mild hypercholesterolemics (Group B)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Severe hypercholesterolemics (Group C)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: High triglycerides (Group D)
Number of subjects: 73
Study: 7589999

Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg for 8 weeks
Number of subjects: 430

Group type: COMPARATOR
Intervention: ranitidine 150 b.i.d. for 8 weeks
Number of subjects: 430
Study: 1688966

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 7232006

Group type: EXPERIMENTAL
Intervention: Electrical tooth pulp stimulation at varying intensities (5 intensities)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Electrical tooth pulp stimulation at varying intensities
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fentanyl (narcotic analgesic)
Number of subjects: 30
Study: 31521532

Group type: EXPERIMENTAL
Intervention: Aerobic exercise on a stationary home-trainer, 30-45 min training three times per week for 6 months, enhanced with virtual reality software and real-life videos.
Number of subjects: 130

Group type: COMPARATOR
Intervention: Stretching (active control group), 30-45 min training three times per week for 6 months.
Number of subjects: 130
Study: 27314762

Group type: EXPERIMENTAL
Intervention: Aloe vera (systemic juice and topical gel) for 3 months
Number of subjects: 74

Group type: COMPARATOR
Intervention: Intralesional injection of hydrocortisone and hyaluronidase with antioxidant supplements for 6 weeks and 3 months respectively
Number of subjects: 74
Study: 25110231

Group type: EXPERIMENTAL
Intervention: Intravenous alcohol administration at two target blood alcohol concentrations (40 and 80 mg%)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline control infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous alcohol administration
Number of subjects: 20
Study: 25043153

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg twice a day and dexamethasone (dex)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Placebo and dexamethasone (dex)
Number of subjects: 430
Study: 21088895

Group type: EXPERIMENTAL
Intervention: Soybean meal (SBM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Partial substitution of SBM with Streblus asper Lour foliage
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Partial substitution of SBM with Leucaena (Leucaena leucocephala) foliage
Number of subjects: 18
Study: 19680667

Group type: EXPERIMENTAL
Intervention: ASARP
Number of subjects: 38

Group type: COMPARATOR
Intervention: PSARP
Number of subjects: 38
Study: 18068514

Group type: EXPERIMENTAL
Intervention: Anacetrapib (0, 10, 40, 150, or 300 mg orally once a day for 28 days)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Anacetrapib (150 mg once a day for 10 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15885163

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 12196048

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (ITM)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Intrathecal placebo (ITP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Subcutaneous (SC) injections of morphine every 4 hours as needed
Number of subjects: 62
Study: 9484732

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (intravenous epirubicin hydrochloride: 8 doses of 40 mg/m2 each at 6-week intervals; transarterial chemotherapy: 3 courses with a maximum dose of 20 mL each at 2-month intervals)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No adjuvant treatment (control group)
Number of subjects: 66
Study: 8548573

Group type: EXPERIMENTAL
Intervention: Three levels of pressure support systems used in association with a risk assessment tool during phase two of the study.
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Modified Norton scoring system used for risk assessment.
Number of subjects: 327
Study: 2505715

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg once a day)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Captopril (25 mg b.d.)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Atenolol (50 mg once a day)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Combined hydrochlorothiazide + amiloride (50 mg + 5 mg once a day)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg once a day) with diuretic
Number of subjects: 165

Group type: COMPARATOR
Intervention: Captopril (25 mg b.d.) with diuretic
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg once a day) with atenolol
Number of subjects: 165

Group type: COMPARATOR
Intervention: Atenolol (50 mg once a day) with diuretic
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg once a day) with beta-blocker
Number of subjects: 165

Group type: COMPARATOR
Intervention: Combined hydrochlorothiazide + amiloride (50 mg + 5 mg once a day) with beta-blocker
Number of subjects: 165
Study: 916947

Group type: EXPERIMENTAL
Intervention: Heparin-Dihydergot
Number of subjects: 2136

Group type: COMPARATOR
Intervention: Low-dose heparin
Number of subjects: 2136

Group type: COMPARATOR
Intervention: Acetylsalicylic-acid (ASS)
Number of subjects: 2136

Group type: COMPARATOR
Intervention: Low molecular weight dextran
Number of subjects: 2136

Group type: COMPARATOR
Intervention: Dihydroergotamine
Number of subjects: 2136
Study: 30896659

Group type: COMPARATOR
Intervention: Microneedling and 660 nm red laser photobiomodulation sham
Number of subjects: 66

Group type: COMPARATOR
Intervention: 660 nm red laser photobiomodulation and microneedling sham
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Microneedling and 660 nm red laser photobiomodulation
Number of subjects: 66
Study: 29683854

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted lopinavir (LPV/r)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Efavirenz (EFV)
Number of subjects: 49
Study: 27349901

Group type: EXPERIMENTAL
Intervention: BI 811283 (Aurora B kinase inhibitor) administered via 24‐h infusion on Days 1 and 15 of a 4‐week cycle (schedule A) or Day 1 of a 3‐week cycle (schedule B)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: BI 811283 (Aurora B kinase inhibitor)
Number of subjects: 121
Study: 24687764

Group type: EXPERIMENTAL
Intervention: Educational documentary video
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 202
Study: 22379336

Group type: EXPERIMENTAL
Intervention: Early enteral feeding (EEN)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 38
Study: 18805649

Group type: EXPERIMENTAL
Intervention: Morning radiotherapy (RT) (8‐10 AM)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Afternoon radiotherapy (RT) (4‐6 PM)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Morning RT
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Morning RT (66‐70 Gy in 33‐35 fractions)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Morning RT (for smokers)
Number of subjects: 216
Study: 18260939

Group type: EXPERIMENTAL
Intervention: Spironolactone (25-75 mg/day)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no spironolactone)
Number of subjects: 49
Study: 16231621

Group type: EXPERIMENTAL
Intervention: SMA circuits (n=20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ACE-inhibited SMA patients (n=11)
Number of subjects: 40
Study: 12116339

Group type: EXPERIMENTAL
Intervention: Accelerated ICE with filgrastim and autologous stem cell support
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard ICE chemotherapy
Number of subjects: 11
Study: 9987705

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 6
Study: 7587900

Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 155

Group type: COMPARATOR
Intervention: metoclopramide
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Zofran (Glaxo)
Number of subjects: 155
Study: 2187981

Group type: EXPERIMENTAL
Intervention: Universal reactors (n = 58)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (n = 55)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Psychologic patients (n = 89)
Number of subjects: 202
Study: 6773727

Group type: EXPERIMENTAL
Intervention: Low-dose insulin therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: High-dose insulin therapy
Number of subjects: 48
Study: 30333270

Group type: EXPERIMENTAL
Intervention: Single dose of DLBS1033 (3 x 490 mg)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Repeated administration of DLBS1033 (3 x 490 mg/day for 3 days)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Safety parameters (creatinine, prothrombin time, activated partial thromboplastin time, SGOT, SGPT)
Number of subjects: 2
Study: 27078119

Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ceftriaxone plus vancomycin (comparator)
Number of subjects: 40
Study: 24450305

Group type: EXPERIMENTAL
Intervention: Custom-made foot orthoses (CFO)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Sham orthoses
Number of subjects: 154
Study: 22752966

Group type: EXPERIMENTAL
Intervention: Vitamin A (10,000 IU per day for 3 months)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 20402381

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) monotherapy (8 mg/kg every 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate monotherapy
Number of subjects: 0
Study: 18756880

Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy (5 mg Prednisolonacetate, anterior H‐inject, Winthorp) administered via parabulbar injections every day/five days
Number of subjects: 475

Group type: COMPARATOR
Intervention: Regular polyvitamine therapy (Lutein, Beta Karoten, Vitamin E)
Number of subjects: 475
Study: 15903378

Group type: EXPERIMENTAL
Intervention: Static stretching (SS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dynamic exercise (DY)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dynamic exercise plus 3 drop jumps from 15-cm boxes (DYJ)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study: 12783161

Group type: EXPERIMENTAL
Intervention: High-volume hemofiltration (HVHF) with lactate-buffered replacement fluids for 8 hours
Number of subjects: 10

Group type: COMPARATOR
Intervention: Continuous venovenous hemofiltration (CVVH) with lactate-buffered replacement fluids for 8 hours
Number of subjects: 10
Study: 10383377

Group type: EXPERIMENTAL
Intervention: Emergency angiography followed by revascularization (PTCA or CABG)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Initial medical management
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Registry patients (not randomized)
Number of subjects: 55
Study: 8786174

Group type: EXPERIMENTAL
Intervention: BK-F membrane (1.3 m2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: BK-P membrane (1.6 m2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cellulose acetate (CA, 1.3 m2)
Number of subjects: 10
Study: 1852664

Group type: EXPERIMENTAL
Intervention: Danazol (100 mg twice daily)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 6341410

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Relaxation
Number of subjects: 87

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 87
Study: 30972712

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 7794

Group type: COMPARATOR
Intervention: Control group (non-event patients with ≥ 180 days of warfarin exposure)
Number of subjects: 7794
Study: 28792105

Group type: EXPERIMENTAL
Intervention: TPTNS plus 20 mg trospium chloride daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: TPTNS alone
Number of subjects: 30
Study: 26807631

Group type: EXPERIMENTAL
Intervention: Intravitreal injections of rtPA, perfluoropropane (C3F8) gas, and bevacizumab (n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vitrectomy with subretinal rtPA administration, intravitreal C3F8 gas, and bevacizumab (n = 12)
Number of subjects: 24
Study: 24293332

Group type: EXPERIMENTAL
Intervention: Multi-compartment compliance aids (MCAs)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (patients refusing MCA)
Number of subjects: 54
Study: 21198965

Group type: EXPERIMENTAL
Intervention: High biotin diet (2000 μg/kg)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: High Zn diet (150 mg/kg)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Mannan-oligosaccharides (MOS) diet (1%)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control diet (300 μg biotin and 50 mg Zn/kg)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Wet litter exposure (27% DM for 8 h daily)
Number of subjects: 116
Study: 21135293

Group type: EXPERIMENTAL
Intervention: Metoprolol (1 to 3 mg/h for 48 hours)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Amiodarone (15 mg/kg daily, max 1000 mg for 48 hours)
Number of subjects: 316
Study: 17893462

Group type: EXPERIMENTAL
Intervention: Management of intracranial venous thrombosis in parturients after regional anesthesia
Number of subjects: 0
Study: 16301237

Group type: EXPERIMENTAL
Intervention: General anesthesia with TIVA (fentanyl and propofol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General anesthesia with F-P-I (fentanyl, thiopental, and isoflurane)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spinal block with 5 mg of 0.5% bupivacaine (LDS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spinal block with 2.5 mg of 0.5% bupivacaine plus 25 mug of fentanyl (SDS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spinal block with 2.5 mg of bupivacaine plus 25 mug of fentanyl (SDS)
Number of subjects: 0
Study: 11988605

Group type: EXPERIMENTAL
Intervention: Visual hemifield stimulation of the unaffected side of stroke patients
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Visual hemifield stimulation of the hemianopic side
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 14
Study: 9816887

Group type: EXPERIMENTAL
Intervention: LP positive patients (group I, 30 patients)
Number of subjects: 56

Group type: COMPARATOR
Intervention: LP negative patients (group II, 26 patients)
Number of subjects: 56
Study: 7621007

Group type: EXPERIMENTAL
Intervention: Diltiazem treatment
Number of subjects: 13

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group with ischemic cardiopathy (no calcium antagonists)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 13
Study: 2658574

Group type: EXPERIMENTAL
Intervention: Empiric amphotericin B
Number of subjects: 132

Group type: COMPARATOR
Intervention: No empiric antifungal therapy (control)
Number of subjects: 132
Study: 5302329

Group type: EXPERIMENTAL
Intervention: High-potency whole-cell cholera vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Purified Ogawa antigen (lipopolysaccharide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholera vaccine
Number of subjects: 0
Study: 31043161

Group type: EXPERIMENTAL
Intervention: Combination of plant sterols (PS) and omega‐3 fatty acids
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Omega‐3 fatty acids alone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Plant sterols (PS) alone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (soy bean powder plus placebo capsules)
Number of subjects: 200
Study: 27749740

Group type: EXPERIMENTAL
Intervention: Pueraria mirifica gel
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conjugated estrogen cream (CEE)
Number of subjects: 82
Study: 25533593

Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual rehabilitation
Number of subjects: 0
Study: 23700131

Group type: EXPERIMENTAL
Intervention: Auditory stimuli presented from the same side as tactile stimuli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Auditory stimuli presented from the opposite side of tactile stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sounds delivered from near the head
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Back of the hand stimulated
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Palm of the hand stimulated
Number of subjects: 0
Study: 16100228

Group type: EXPERIMENTAL
Intervention: Computer training
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Group training
Number of subjects: 76

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 76
Study: 12548439

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory diet (AID) with arachidonic acid intake of less than 90 mg/day
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Fish oil capsules (30 mg/kg body weight)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: AID with fish oil
Number of subjects: 68

Group type: COMPARATOR
Intervention: Normal western diet (WD)
Number of subjects: 68
Study: 11097588

Group type: EXPERIMENTAL
Intervention: Eye rubbing (15 times) without exposure to allergens
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Eye rubbing (15 times) after exposure to cat dander
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Eye rubbing (20 times with more force) after exposure to cat dander
Number of subjects: 33
Study: 8857871

Group type: EXPERIMENTAL
Intervention: HMO enrollment for severely mentally ill subjects
Number of subjects: 250

Group type: COMPARATOR
Intervention: HMO enrollment for controls without diabetes mellitus
Number of subjects: 250

Group type: COMPARATOR
Intervention: HMO enrollment for patients with diabetes mellitus
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Community mental health service use among severely mentally ill subjects
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: HMO costs of care per member per month for severely mentally ill subjects
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Use of general medical care among severely mentally ill subjects
Number of subjects: 250
Study: 1320416

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Logiparin)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 6472365

Group type: EXPERIMENTAL
Intervention: Acetohydroxamic acid (15 mg per kilogram of body weight per day, in divided oral doses)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Acetohydroxamic acid
Number of subjects: 37
Study: 31816018

Group type: EXPERIMENTAL
Intervention: Intra-arterial urokinase
Number of subjects: 993
Study: 31155667

Group type: EXPERIMENTAL
Intervention: SIPPC‐RE (Reinforcement Learning and Error‐Based Learning)
Number of subjects: 30

Group type: COMPARATOR
Intervention: SIPPC‐R (Reinforcement Learning only)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SIPPC‐TD (Typically Developing)
Number of subjects: 30
Study: 27384376

Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg every 8 hours)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Acetaminophen (1 g every 6 hours)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 113

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both Ibuprofen and Acetaminophen
Number of subjects: 113
Study: 25717250

Group type: EXPERIMENTAL
Intervention: LC+IOC treatment
Number of subjects: 371

Group type: COMPARATOR
Intervention: Routine LC treatment
Number of subjects: 371
Study: 23981814

Group type: EXPERIMENTAL
Intervention: Combination of inositol and alpha lipoic acid
Number of subjects: 155
Study: 21254162

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Emtricitabine/TDF (FTC/TDF)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV)
Number of subjects: 112
Study: 19065672

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lamivudine add‐on
Number of subjects: 0
Study: 17708158

Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia solution with Technetium (Tc-99m) tracer
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia solution
Number of subjects: 20
Study: 15113965

Group type: EXPERIMENTAL
Intervention: Daily supervised iron supplementation [3-6 mg/(kg.d)]
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Twice weekly supervised iron supplementation [6-12 mg/(kg.wk)]
Number of subjects: 1049

Group type: EXPERIMENTAL
Intervention: Daily unsupervised iron supplementation
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Twice weekly unsupervised iron supplementation
Number of subjects: 1049
Study: 12040766

Group type: EXPERIMENTAL
Intervention: Hatha yogic exercises for 1 hour every morning, 6 days a week for six months
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hatha yogic exercises
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional physical exercise training (PT)
Number of subjects: 28
Study: 9701417

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (600 microg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Orciprenaline sulphate (2.25 mg)
Number of subjects: 0
Study: 7838917

Group type: EXPERIMENTAL
Intervention: Flumazenil (2 mg in saline)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl in water)
Number of subjects: 30
Study: 3171331

Group type: EXPERIMENTAL
Intervention: Topical prostaglandin E2 (0.02% solution)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical prostaglandin E2
Number of subjects: 0